Skip to main content
Clinical Trials/IRCT20190727044343N4
IRCT20190727044343N4
Completed
Phase 3

The effectivenees of N-acetylcysteine (NAC) on accelerating renal failer recovery in patient with leptospirosis in Razi Hospital of Ghaemshahr city 2019

Mazandaran University of Medical Sciences0 sites64 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mazandaran University of Medical Sciences
Enrollment
64
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • People with Glomerular Filteration Rate (GFR) have less than 60 studies.
  • People whose leptospirosis has been confirmed by Enzym\-Linked Immunosorbent Assay (ELISA) or Microscopic Agglutination Test (MAT) .
  • Satisfaction to participate in the study.

Exclusion Criteria

  • Diabetics are excluded from the study.
  • People with underlying liver disease are excluded from the study.
  • People with underlying kidney disease excluded from the study.
  • Patients who have been hospitalized with sepsis symptoms prior to refferal.

Outcomes

Primary Outcomes

Not specified

Similar Trials